There's a fine line when it comes to using ketamine -- and from Chrissy Teigen to Matthew Perry, these stars have explored it ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental health conditions. However, they may cover the FDA-approved nasal spray, ...
Ketamine is a short-acting anesthetic that has been used for decades in medical settings. In recent years, researchers have ...
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
A new study finds that oral ketamine significantly reduces PTSD symptoms, with 73% of participants seeing a 50% reduction in ...
Celebrities like Matthew Perry, Chrissy Teigen and others have been open about using ketamine infusion therapy to help treat mental health conditions. According to the United States Drug ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
The symptoms of mental health disorders and chronic pain affect every facet of life, especially during the dark, cold days of ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
Depression is a pervasive mental health condition affecting millions of people worldwide. It can manifest in various ways, from persistent sadness to a lack of energy or interest in daily activities.
Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...
This can then be followed by a dexmedetomidine infusion (1–2 μg/kg/hr) with supplemental bolus doses of ketamine (0.5–1 mg/kg) as needed. Conclusions: The available literature except for one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results